HomeOpen Access NewsDrug Development

Drug Development

Weekly Levodopa-Carbidopa injection could revolutionise Parkinson’s care

A University of South Australia team has developed a weekly biodegradable injection of levodopa and carbidopa, offering seven-day release to ease dosing and boost adherence for Parkinson’s patients.

Increasing blood-brain barrier permeability with Acoustic Cluster Therapy (ACT®) to enhance drug delivery in the brain

Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.

The UK CBD Market: Cannabinoids, Consumers and Confusion

Savage Cabbage Ltd give insight into the UK CBD market, defining the differences in cannabinoid products and their roles in the industry.

Tackling antimicrobial resistance: A digital approach

Reflecting on the recent World Antimicrobial Awareness Week (WAAW 2022), it’s evident that we must continue to raise better awareness and understanding of antimicrobial resistance, which is one of the top 10 global public health threats facing humanity.

New drug ‘Lecanemab’ slows the effects of Alzheimer’s disease

After decades of failure for Alzheimer’s researchers, Lecanemab could open the door to a new ear of drugs to treat Alzheimer’s disease – the world's most common form of dementia.

Legalization of recreational cannabis linked with increased alcohol consumption

States that oversaw the legalization of recreational cannabis linked to increased alcohol consumption that is largely driven by young adults and men.

COVID-19, communicable disease and immunology

Academic Research Scholar, Prof Wendy M. Purcell, provides an update on COVID-19, communicable disease and immunology.

Ayahuasca dangers: mental and physical adverse effects

A survey looking at ayahuasca dangers finds 70% experience physical and 55% mental health adverse effects – but only 2.3% of physical adverse events require medical attention.

Hepatitis C virus elimination: A potential global success story

Dr Zisis Kozlakidis and Dr Dewi Nur Aisyah examine Hepatitis C virus elimination and weigh up if this has the potential to become a global success story.

Germany becomes one of the first European countries to legalise cannabis

Germany has made plans to legalise cannabis, which could create up to 27,000 new jobs and save around about 4.7 billion euros.

Do you really need to be taking paracetamol?

Paracetamol is Britain’s most trusted painkiller with the average person taking up to 70 paracetamol per year, however there are safety issues.

A blueprint for the UK Cannabis Industry

Senior Associate David Hardstaff and Partner John Binns of BCL Solicitors LLP, share their views on a blueprint for the UK Cannabis Industry.

Diabetes education to protect tomorrow

Prof Andrew Boulton, President, International Diabetes Federation, calls for more to be done to improve access to diabetes education.

Tuberculosis drug regimens and their efficacies

Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.

What’s the connection between menopause and weight gain?

The relation between menopause, BMI, hormones and weight gain is a complex one that many going through menopause don't really understand here menopause expert Dr Deborah Lee explains.

Benefits of animal vaccination for animals & people

Roxane Feller, Secretary General of AnimalhealthEurope, helps us understand the benefits of animal vaccination for both animals and people.

What are the mental and physical health benefits of essential oils?

Essential oils have been used for centuries for their medicinal properties. However, scientists have only now started studying and exploring the potential benefits of essential oils.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders